AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 150 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,445,000 | -69.3% | 117,434 | -69.3% | 0.56% | -69.3% |
| Q3 2016 | $14,459,000 | +128.2% | 383,118 | +6.4% | 1.82% | +102.1% |
| Q2 2016 | $6,336,000 | +37.1% | 360,004 | -5.3% | 0.90% | +47.4% |
| Q1 2016 | $4,623,000 | +9.9% | 380,190 | +120.1% | 0.61% | +23.5% |
| Q4 2015 | $4,207,000 | -21.3% | 172,763 | -42.7% | 0.49% | -20.3% |
| Q3 2015 | $5,345,000 | +75.9% | 301,293 | +75.1% | 0.62% | +100.6% |
| Q2 2015 | $3,038,000 | – | 172,115 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |